| Financial Year |
March 31 2023 |
| Monetary Funds |
640,094,895.03 |
| Held-for-trading Financial Assets |
12,456,446.03 |
| Notes Receivable |
-- |
| Accounts Receivable |
22,095,453.46 |
| Advances to Suppliers |
8,607,610.16 |
| Other Receivables |
32,058,022.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
305,348,318.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
42,982,103.56 |
| Total Current Assets |
1,063,642,849.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
867,867,878.81 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
90,472,941.29 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
85,806,327.63 |
| Deferred Income Tax Assets |
32,933,236.54 |
| Other Non-Current Assets |
2,610,073,839.52 |
| Sub-Total of Non-Current Assets |
4,014,607,821.21 |
| Total Assets |
5,078,250,670.94 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
335,396,238.41 |
| Accounts Received In Advance |
10,929,233.73 |
| Employee Compensation Payable |
73,647,685.54 |
| Taxes Payable |
31,604,904.34 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
126,271,587.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
82,048,625.76 |
| Other Current Liabilities |
89,203,799.00 |
| Sub-Total of Current Liabilities |
1,606,338,971.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
274,488,891.85 |
| Total Liabilities |
1,880,827,863.55 |
| Paid-In Capital(Or Share Stock) |
547,678,400.00 |
| Capital Surplus |
1,989,326,445.12 |
| Surplus Reserve |
168,005,141.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
492,412,820.41 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,197,422,807.39 |
| Owner's Equity（Stockholder's Equity） |
3,197,422,807.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,078,250,670.94 |
